Skip to main content
Clinical Trials/JPRN-UMIN000017230
JPRN-UMIN000017230
Recruiting
未知

Correlation between efficacy of the biological therapy (tocilizumab) and levels of oxidative stress markers in Japanese patients with rheumatoid arthritis (inadequate responders to existing therapies) - Correlation between efficacy of the biological therapy (tocilizumab) and levels of oxidative stress markers in Japanese patients with rheumatoid arthritis (inadequate responders to existing therapies)

Kyushu University0 sites60 target enrollmentApril 22, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Rheumatoid arthritis
Sponsor
Kyushu University
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 22, 2015
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)The patients have an obvious infection in by just before treatment administration, and research investigator or research sharing doctor has determined that they are inappropriate for this study. 2\)Based on the Japan College of Rheumatology "tocilizumab use guidelines for rheumatoid arthritis (2012 Revised Edition)", the patients correspond to the administration contraindication 3\)The Patients who were considered as inappropriate by the other research doctors based on the medical backgrounds. 4\)Under 20 years old

Outcomes

Primary Outcomes

Not specified

Similar Trials